134 related articles for article (PubMed ID: 38788146)
61. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.
Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557
[TBL] [Abstract][Full Text] [Related]
62. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.
Mills SA; Oh MC; Rutkowski MJ; Sughrue ME; Barani IJ; Parsa AT
Neuro Oncol; 2012 Aug; 14(8):1097-104. PubMed ID: 22723428
[TBL] [Abstract][Full Text] [Related]
63. Growth rate and fate of untreated hemangioblastomas: clinical assessment of the experience of a single institution.
Byun J; Yoo HJ; Kim JH; Kim YH; Cho YH; Hong SH; Kim CJ
J Neurooncol; 2019 Aug; 144(1):147-154. PubMed ID: 31201685
[TBL] [Abstract][Full Text] [Related]
64. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
65. Retrobulbar Hemangioblastomas in von Hippel-Lindau Disease: Clinical Course and Management.
Alvarez R; Mastorakos P; Hogan E; Scott G; Lonser RR; Wiley HE; Chew EY; Chittiboina P
Neurosurgery; 2021 Apr; 88(5):1012-1020. PubMed ID: 33442737
[TBL] [Abstract][Full Text] [Related]
66. Von Hippel-Lindau disease.
Chittiboina P; Lonser RR
Handb Clin Neurol; 2015; 132():139-56. PubMed ID: 26564077
[TBL] [Abstract][Full Text] [Related]
67. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.
Corcos O; Couvelard A; Giraud S; Vullierme MP; Dermot O'Toole ; Rebours V; Stievenart JL; Penfornis A; Niccoli-Sire P; Baudin E; Sauvanet A; Levy P; Ruszniewski P; Richard S; Hammel P
Pancreas; 2008 Jul; 37(1):85-93. PubMed ID: 18580449
[TBL] [Abstract][Full Text] [Related]
68. Multiple spinal "miliary" hemangioblastomas in von Hippel-Lindau (vHL) disease without cerebellar involvement. A case report and review of the literature.
Roessler K; Dietrich W; Haberler C; Goerzer H; Czech T
Neurosurg Rev; 1999 Oct; 22(2-3):130-4. PubMed ID: 10547014
[TBL] [Abstract][Full Text] [Related]
69. Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature.
Goto T; Nishi T; Kunitoku N; Yamamoto K; Kitamura I; Takeshima H; Kochi M; Nakazato Y; Kuratsu J; Ushio Y
Surg Neurol; 2001 Jul; 56(1):22-6. PubMed ID: 11546565
[TBL] [Abstract][Full Text] [Related]
70. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
71. Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors.
Zhuang Z; Frerich JM; Huntoon K; Yang C; Merrill MJ; Abdullaev Z; Pack SD; Shively SB; Stamp G; Lonser RR
Sci Rep; 2014 Feb; 4():4102. PubMed ID: 24531117
[TBL] [Abstract][Full Text] [Related]
72. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
Kim BY; Jonasch E; McCutcheon IE
Target Oncol; 2012 Jun; 7(2):145-9. PubMed ID: 22374327
[TBL] [Abstract][Full Text] [Related]
73. Sacral hemangioblastoma in a patient with von Hippel-Lindau disease. Case report and review of the literature.
Pluta RM; Wait SD; Butman JA; Leppig KA; Vortmeyer AO; Oldfield EH; Lonser RR
Neurosurg Focus; 2003 Aug; 15(2):E11. PubMed ID: 15350042
[TBL] [Abstract][Full Text] [Related]
74. Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease.
Gläsker S; Klingler JH; Müller K; Würtenberger C; Hader C; Zentner J; Neumann HP; Velthoven VV
Cent Eur Neurosurg; 2010 May; 71(2):80-7. PubMed ID: 20229452
[TBL] [Abstract][Full Text] [Related]
75. Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease.
Frantzen C; Kruizinga RC; van Asselt SJ; Zonnenberg BA; Lenders JW; de Herder WW; Walenkamp AM; Giles RH; Hes FJ; Sluiter WJ; van Pampus MG; Links TP
Neurology; 2012 Aug; 79(8):793-6. PubMed ID: 22875085
[TBL] [Abstract][Full Text] [Related]
76. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease.
Asthagiri AR; Mehta GU; Zach L; Li X; Butman JA; Camphausen KA; Lonser RR
Neuro Oncol; 2010 Jan; 12(1):80-6. PubMed ID: 20150370
[TBL] [Abstract][Full Text] [Related]
77. Ocular clusterin expression in von Hippel-Lindau disease.
Zhou M; Shen D; Head JE; Chew EY; Chévez-Barrios P; Green WR; Chan CC
Mol Vis; 2007 Nov; 13():2129-36. PubMed ID: 18079682
[TBL] [Abstract][Full Text] [Related]
78. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.
Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
Orphanet J Rare Dis; 2024 Feb; 19(1):73. PubMed ID: 38365728
[TBL] [Abstract][Full Text] [Related]
79. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.
Arao T; Okada Y; Tanikawa T; Inatomi H; Shuin T; Fujihira T; Yamashita H; Tanaka Y
Endocr J; 2002 Apr; 49(2):181-8. PubMed ID: 12081237
[TBL] [Abstract][Full Text] [Related]
80. Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature.
Wang X; Haines GK; Mehrotra M; Houldsworth J; Si Q
Diagn Pathol; 2022 Feb; 17(1):34. PubMed ID: 35220972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
